pediatric

FDA accepts Roche’s NDA for Xofluza to treat influenza in children
FDA accepts Roche’s NDA for Xofluza to treat influenza in children
Pharmaceutical Business Review
Roche
FDA
pediatric
Xofluza
Flag link:
Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa
Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa
BioSpace
Pfizer
FDA
Eucrisa
pediatric
atopic dermatitis
Flag link:
FDA Approves Gilead’s Epclusa for Children with Hepatitis C
FDA Approves Gilead’s Epclusa for Children with Hepatitis C
BioSpace
Epclusa
hepatitis C
Gilead Sciences
FDA
pediatric
Flag link:
Forty Seven, Rocket collaborate on new treatment for Fanconi Anemia
Forty Seven, Rocket collaborate on new treatment for Fanconi Anemia
Pharmaceutical Business Review
Forty Seven
Rocket Pharmaceuticals
R&D
Fanconi Anemia
pediatric
Flag link:
Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials
Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials
Xconomy
Teva Pharmaceutical
pediatric
Tourette syndrome
clinical trials
deutetrabenazine
Flag link:
FDA Approves Merck's Dificid for Infections in Children
FDA Approves Merck's Dificid for Infections in Children
Motley Fool
FDA
Merck
Dificid
pediatric
C. difficile
Flag link:
Fostering Oncology Product Development for Kids with Cancer
Fostering Oncology Product Development for Kids with Cancer
FDA Law Blog
pediatric
oncology
FDA
drug development
Flag link:
GSK's ViiV seeks marketing license for baby-friendly HIV pill
GSK's ViiV seeks marketing license for baby-friendly HIV pill
Reuters
GSK
HIV
Dolutegravir
pediatric
Flag link:
When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance
When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance
RAPS.org
FDA
cancer
oncology
pediatric cancer
pediatric
Flag link:
FDA Approves Contact that Slows Nearsightedness Progression
FDA Approves Contact that Slows Nearsightedness Progression
RAPS.org
CooperVision
contact lens
pediatric
myopia
devices
FDA
MiSight lenses
Flag link:
Everything Old is New Again: FDA Revises its 2014 Rare Pediatric Disease Priority Review Voucher Guidance for Industry
Everything Old is New Again: FDA Revises its 2014 Rare Pediatric Disease Priority Review Voucher Guidance for Industry
FDA Law Blog
FDA
priority review
priority review vouchers
pediatric
Flag link:
Roche’s flu drug Xofluza meets primary endpoint in phase III children study
Roche’s flu drug Xofluza meets primary endpoint in phase III children study
Pharmaceutical Business Review
Roche
clinical trials
Xofluza
pediatric
influenza
Flag link:
More than a mascot: Aflac duck robot comforts kid cancer patients—and sets an example for pharma
More than a mascot: Aflac duck robot comforts kid cancer patients—and sets an example for pharma
Fierce Pharma
cancer
pediatric
devices
drug advertising
Flag link:
Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors
Allergan’s Botox Approved for Pediatric Limb Spasticity Amid Split-Up Rumors
Endpoints
Allergan
FDA
Botox
pediatric
upper limb spasticity
Flag link:
Researchers ID 14 Genes Linked to Survival in Pediatric Liver Disease
Researchers ID 14 Genes Linked to Survival in Pediatric Liver Disease
BioSpace
pediatric
liver disease
genes
biliary atresia
Flag link:
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Pharmaforum
Novo Nordisk
Victoza
type 2 diabetes
pediatric
Flag link:
GSK seeks pediatric indication for Nucala in severe eosinophilic asthma
GSK seeks pediatric indication for Nucala in severe eosinophilic asthma
Pharmaceutical Business Review
GSK
Nucala
pediatric
eosinophilic asthma
Flag link:
FDA mandates pediatric trials for 200 cancer targets
FDA mandates pediatric trials for 200 cancer targets
BioCentury
FDA
pediatric
clinical trials
oncology
cancer
Flag link:
Teva’s Granix Gets FDA Approval for Expanded Indication
Teva’s Granix Gets FDA Approval for Expanded Indication
Market Realist
Teva Pharmaceutical
Granix
pediatric
neutropenia
Flag link:
GSK’s Arnuity Ellipta asthma therapy wins FDA nod for use in kids as young as 5 years old
GSK’s Arnuity Ellipta asthma therapy wins FDA nod for use in kids as young as 5 years old
Drug Delivery Business News
GSK
FDA
Arnuity Ellipta
asthma
pediatric
Flag link:

Pages